Market Trends: Biologics Clinical Manufacturing CDMO Service

Vast range of products, services catered to requirements of market segments and clientele groups make up biologics clinical manufacturing CDMO service market.

CDMOs Offering Unique Options To Meet Cold Chain Demands

To meet rising demand for CGT products, CDMOs have an approach to investing in enhancing their cold chain solutions via the use of cutting-edge technologies.

Can Clinical Research Spectrum Make The Most of Gene Therapy

Goal of gene therapy is to manage risks without limiting creativity and to make sure the trial development procedure complies with legal, clinical requirements.

Cell & Gene Therapies: FDA Regulatory Considerations In 2024

The FDA went on to establish a super office called the office of therapeutic products in order to handle the growing overload from cell and gene therapies.

US Enacts Biosecurity Law Blocking Chinese Bio Company Deals

As bio can be next in line target after semiconductors & batteries, US Congress has enacted biosecurity law restricting transactions with Chinese bio firms.